These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32971537)

  • 1. High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments.
    Al-Dujaili AH; Mousa RF; Al-Hakeim HK; Maes M
    Schizophr Bull; 2021 Mar; 47(2):530-541. PubMed ID: 32971537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In schizophrenia, non-remitters and partial remitters to treatment with antipsychotics are qualitatively distinct classes with respect to neurocognitive deficits and neuro-immune biomarkers: results of soft independent modeling of class analogy.
    Al-Hakeim HK; Mousa RF; Al-Dujaili AH; Maes M
    Metab Brain Dis; 2021 Jun; 36(5):939-955. PubMed ID: 33580860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6.
    Moustafa SR; Al-Rawi KF; Stoyanov D; Al-Dujaili AH; Supasitthumrong T; Al-Hakeim HK; Maes M
    Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32858974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates.
    Mousa RF; Al-Hakeim HK; Alhaideri A; Maes M
    Metab Brain Dis; 2021 Jan; 36(1):169-183. PubMed ID: 32965599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In schizophrenia, immune-inflammatory pathways are strongly associated with depressive and anxiety symptoms, which are part of a latent trait which comprises neurocognitive impairments and schizophrenia symptoms.
    Almulla AF; Al-Rawi KF; Maes M; Al-Hakeim HK
    J Affect Disord; 2021 May; 287():316-326. PubMed ID: 33812245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study.
    Al-Hakeim HK; Almulla AF; Maes M
    Neurotox Res; 2020 Mar; 37(3):753-771. PubMed ID: 31916129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity.
    Maes M; Sirivichayakul S; Matsumoto AK; Maes A; Michelin AP; de Oliveira Semeão L; de Lima Pedrão JV; Moreira EG; Barbosa DS; Geffard M; Carvalho AF; Kanchanatawan B
    Mol Neurobiol; 2020 May; 57(5):2333-2345. PubMed ID: 32040834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions.
    Sirivichayakul S; Kanchanatawan B; Thika S; Carvalho AF; Maes M
    CNS Neurol Disord Drug Targets; 2019; 18(2):124-140. PubMed ID: 30451122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients.
    Sirivichayakul S; Kanchanatawan B; Thika S; Carvalho AF; Maes M
    Neurotox Res; 2019 Jan; 35(1):122-138. PubMed ID: 30056534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the changes of serum high mobility group protein B1 and cytokines in first-episode schizophrenia patients].
    Zhu Q; Li X; Hie G; Yuan X; Lü L; Song X
    Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(47):3818-22. PubMed ID: 27337797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways.
    Almulla AF; Al-Hakeim HK; Abed MS; Carvalho AF; Maes M
    Schizophr Res; 2020 Aug; 222():342-353. PubMed ID: 32467068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowered serum cesium levels in schizophrenia: association with immune-inflammatory biomarkers and cognitive impairments.
    Almulla AF; Moustafa SR; Al-Dujaili AH; Al-Hakeim HK; Maes M
    Braz J Psychiatry; 2021; 43(2):131-137. PubMed ID: 32556004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakdown of the Paracellular Tight and Adherens Junctions in the Gut and Blood Brain Barrier and Damage to the Vascular Barrier in Patients with Deficit Schizophrenia.
    Maes M; Sirivichayakul S; Kanchanatawan B; Vodjani A
    Neurotox Res; 2019 Aug; 36(2):306-322. PubMed ID: 31077000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde.
    Maes M; Sirivichayakul S; Kanchanatawan B; Carvalho AF
    World J Biol Psychiatry; 2020 Jun; 21(5):383-401. PubMed ID: 32031479
    [No Abstract]   [Full Text] [Related]  

  • 15. Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia.
    Kanchanatawan B; Sriswasdi S; Maes M
    Metab Brain Dis; 2019 Feb; 34(1):267-282. PubMed ID: 30467771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics.
    Maes M; Bocchio Chiavetto L; Bignotti S; Battisa Tura G; Pioli R; Boin F; Kenis G; Bosmans E; de Jongh R; Lin A; Racagni G; Altamura CA
    Eur Neuropsychopharmacol; 2000 Mar; 10(2):119-24. PubMed ID: 10706993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: Results of unsupervised machine learning analysis.
    Kanchanatawan B; Sriswasdi S; Thika S; Stoyanov D; Sirivichayakul S; Carvalho AF; Geffard M; Maes M
    J Eval Clin Pract; 2018 Aug; 24(4):879-891. PubMed ID: 29790237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative genetics of circulating Dickkopf-related protein 1 (DKK1) in community-based sample of UK twins.
    Prakash J; Williams FM; Trofimov S; Surdulescu G; Spector T; Livshits G
    Osteoporos Int; 2016 Jun; 27(6):2065-75. PubMed ID: 26762129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of Plasma Growth Factors and Chemokines in Cocaine Use Disorder: Implications for Dual Diagnosis with Schizophrenia and Antisocial Personality Disorder in an Exploratory Study.
    Torres-Galván S; Flores-López M; Ochoa E; Requena-Ocaña N; Araos P; Herrera-Imbroda J; Muga R; Serrano A; Rodríguez de Fonseca F; Pavón-Morón FJ; Haro G; García-Marchena N
    Neuropsychobiology; 2024; 83(2):73-88. PubMed ID: 38768577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.
    Kanchanatawan B; Maes M
    CNS Neurol Disord Drug Targets; 2018; 17(6):473-486. PubMed ID: 29968545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.